Concepedia

Author

Ami Batchelder

University of Washington

Also Known As

A BATCHELDER, A Batchelder, A L Batchelder, A. Batchelder, Ami Batchelder, Ami L. Batchelder

15

Publications

965

Citations

12

H-Index

23

Concepts

All Affiliations

University of WashingtonFred Hutch Cancer CenterCape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South AfricaSeattle University
AB

About

Ami Batchelder is an author at University of Washington specializing in medicine, transplantation, and hematology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

4

4

202

2

Health Sciences

2

2

140

3

Immunology

2

2

62

4

Blood Transplantation

1

1

127

5

Nephrology

1

1

127

Ami Batchelder

×

11

Publications

925

Citations

11

H-Index

YearCitations

Cyclophosphamide metabolism, liver toxicity, and mortality following hematopoietic stem cell transplantation

George B. McDonald, John T. Slattery, M Bouvier,

Blood

2003

379

Acute renal failure after myeloablative hematopoietic cell transplant: Incidence and risk factors

Sangeeta Hingorani, Katherine A. Guthrie, Ami Batchelder,

Kidney International

2004

127

Cyclophosphamide following Targeted Oral Busulfan as Conditioning for Hematopoietic Cell Transplantation: Pharmacokinetics, Liver Toxicity, and Mortality

Jeannine S. McCune, Ami Batchelder, H. Joachim Deeg,

Biology of Blood and Marrow Transplantation

2007

97

Cyclophosphamide followed by Intravenous Targeted Busulfan for Allogeneic Hematopoietic Cell Transplantation: Pharmacokinetics and Clinical Outcomes

Andrew R. Rezvani, Jeannine S. McCune, Barry E. Storer,

Biology of Blood and Marrow Transplantation

2013

82

Personalized Dosing of Cyclophosphamide in the Total Body Irradiation–Cyclophosphamide Conditioning Regimen: A Phase II Trial in Patients With Hematologic Malignancy

Ami Batchelder, KA Guthrie, Robert P. Witherspoon,

Clinical Pharmacology & Therapeutics

2009

80

Prolonged anorexia and elevated plasma cytokine levels following myeloablative allogeneic hematopoietic cell transplant

Frances R. Malone, Wendy M. Leisenring, Barry E. Storer,

Bone Marrow Transplantation

2007

46

Metabolism-based cyclophosphamide dosing for hematopoietic cell transplant

G MCDONALD, Jeannine S. McCune, Ami Batchelder,

Clinical Pharmacology & Therapeutics

2005

34

Fluconazole Coadministration Concurrent with Cyclophosphamide Conditioning May Reduce Regimen-Related Toxicity Postmyeloablative Hematopoietic Cell Transplantation

Arlo Upton, Jeannine S. McCune, Katharine A. Kirby,

Biology of Blood and Marrow Transplantation

2007

29

Diminishing the risk of nonrelapse mortality in hematopoietic stem cell transplantation: Prediction of exposure to the cyclophosphamide metabolite carboxyethylphosphoramide mustard

Ruolun Qiu, P. Vicini, G MCDONALD,

Clinical Pharmacology & Therapeutics

2004

22

Pharmacogenomic associations in ABCB1 and CYP3A5 with acute kidney injury and chronic kidney disease after myeloablative hematopoietic cell transplantation

Erica L. Woodahl, Sangeeta Hingorani, Jue Wang,

The Pharmacogenomics Journal

2007

16

Page 1